AbbVie Inc. (ABBV) earnings
ABBV earnings moved a median of +0.10% by the close. Quarterly and annual ABBV reports and results, each read against the price at its own news timestamp. Back to the ABBV overview →
36 measured ABBV earnings events.
Where these ABBV earnings landedvs 36 measured ABBV earnings reactions
| Middle 50% of ABBV earnings reactions | -0.85% to +1.25% |
|---|---|
| Median reaction (to close) | +0.10% |
| Measured reactions | 36 |
Point-in-time · zero look-ahead
Half of the 36 ABBV earnings events with a measured close landed between -0.85% and +1.25%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q AbbVie Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.10% | -0.56% | |
| AbbVie Reports Second-Quarter 2026 Financial Results | Press release | +2.51% | +1.59% | |
| AbbVie to Host Second-Quarter 2026 Earnings Conference Call | Press release | +0.91% | +3.25% | |
| Form 10-Q AbbVie Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.02% | +0.27% | |
| AbbVie Reports First-Quarter 2026 Financial Results | Press release | +3.00% | +6.41% | |
| AbbVie to Host First-Quarter 2026 Earnings Conference Call | Press release | +0.32% | +1.13% | |
| Form 10-K AbbVie Inc. For: Dec 31 | SEC filing · Form 10-K | -0.06% | -0.71% | |
| AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results | Press release | +1.28% | +5.91% | |
| AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call | Press release | +0.76% | +3.84% | |
| Form 10-Q AbbVie Inc. For: Sep 30 | SEC filing · Form 10-Q | — | +0.09% | |
| AbbVie Reports Third-Quarter 2025 Financial Results | Press release | -2.00% | -2.60% | |
| AbbVie to Host Third-Quarter 2025 Earnings Conference Call | Press release | +0.44% | -1.80% | |
| Form 10-Q AbbVie Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.04% | +0.30% | |
| AbbVie Reports Second-Quarter 2025 Financial Results | Press release | +0.35% | -3.07% | |
| AbbVie to Host Second-Quarter 2025 Earnings Conference Call | Press release | +0.62% | +1.88% | |
| Form 10-Q AbbVie Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.10% | -1.24% | |
| AbbVie Reports First-Quarter 2025 Financial Results | Press release | -0.63% | -0.50% | |
| AbbVie to Host First-Quarter 2025 Earnings Conference Call | Press release | +0.12% | +2.40% | |
| Form 10-K AbbVie Inc. For: Dec 31 | SEC filing · Form 10-K | +0.10% | -0.51% | |
| AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results | Press release | +0.53% | -2.18% | |
| AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call | Press release | -0.17% | +0.78% | |
| Form 10-Q AbbVie Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.11% | -0.47% | |
| AbbVie Reports Third-Quarter 2024 Financial Results | Press release | -0.24% | +5.00% | |
| AbbVie to Host Third-Quarter 2024 Earnings Conference Call | Press release | -0.20% | -0.33% | |
| Form 10-Q AbbVie Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.16% | +0.45% | |
| AbbVie Reports Second-Quarter 2024 Financial Results | Press release | +1.97% | +4.70% | |
| AbbVie to Host Second-Quarter 2024 Earnings Conference Call | Press release | -0.46% | -1.43% | |
| Form 10-Q AbbVie Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.07% | +0.83% | |
| AbbVie Reports First-Quarter 2024 Financial Results | Press release | -1.14% | -4.42% | |
| AbbVie to Host First-Quarter 2024 Earnings Conference Call | Press release | -0.57% | -5.51% | |
| Form 10-K AbbVie Inc. For: Dec 31 | SEC filing · Form 10-K | +0.06% | -1.04% | |
| AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results | Press release | -1.44% | -0.78% | |
| AbbVie to Host Full-Year and Fourth-Quarter 2023 Earnings Conference Call | Press release | -0.29% | +0.62% | |
| Form 10-Q AbbVie Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.04% | -0.42% | |
| AbbVie Reports Third-Quarter 2023 Financial Results | Press release | +1.41% | +0.12% | |
| AbbVie to Host Third-Quarter 2023 Earnings Conference Call | Press release | +0.57% | +0.93% |
Keep exploring
More ABBV: analyst actions → · SEC filings → · ABBV overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Pfizer, Inc. (PFE) | 729 | -0.02% | 46% |
| Myovant Sciences Ltd. Common Shares (MYOV) | 728 | 0.00% | 49% |
| ESSA Pharma Inc. (EPIX) | 723 | 0.00% | 39% |
| RETROPHIN INC (RTRX) | 723 | +0.06% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.